The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 7/Signature 1
From BugSigDB
Source: figure 7
Description: the most differentially abbundant taxa after the initiation of DS therapy at 0-6months timepoint included overrepresentation of the geus level
Abundance in Group 1: increased abundance in DBS(deep brain stimulation)
| NCBI | Quality Control | Links |
|---|---|---|
| Prevotella |
Revision editor(s): Bolanle
